Literature DB >> 12963123

Sphingosine-1-phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells.

James R Van Brocklyn1, Nicholas Young, Rosemary Roof.   

Abstract

Sphingosine-1-phosphate (S1P) is a bioactive lipid which is a potent mitogen for glioblastoma multiforme cells. Here we show that S1P also potently enhances the in vitro motility of glioblastoma cells by signaling through receptors coupled to G(i/o) proteins. Moreover, S1P also enhanced in vitro invasion of glioblastoma cells through Matrigel. S1P had no effect on matrix metalloproteinase secretion but did enhance glioblastoma cell adhesion. S1P is present at high levels in brain tissue. Thus it is possible that autocrine or paracrine signaling by S1P through its G protein-coupled receptors enhances both glioma cell proliferation and invasiveness.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12963123     DOI: 10.1016/s0304-3835(03)00334-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  42 in total

Review 1.  G protein-coupled receptors as oncogenic signals in glioma: emerging therapeutic avenues.

Authors:  A E Cherry; N Stella
Journal:  Neuroscience       Date:  2014-08-24       Impact factor: 3.590

2.  Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells.

Authors:  Sonja Balthasar; Johanna Samulin; Hanna Ahlgren; Nina Bergelin; Mathias Lundqvist; Emil C Toescu; Margaret C Eggo; Kid Törnquist
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

3.  Sphingosine-1-phosphate and calcium signaling in cerebellar astrocytes and differentiated granule cells.

Authors:  Paola Giussani; Anita Ferraretto; Claudia Gravaghi; Rosaria Bassi; Guido Tettamanti; Laura Riboni; Paola Viani
Journal:  Neurochem Res       Date:  2006-12-07       Impact factor: 3.996

4.  Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma.

Authors:  A Palangi; N Shakhssalim; M Parvin; S Bayat; A Allameh
Journal:  Clin Transl Oncol       Date:  2019-02-02       Impact factor: 3.405

5.  Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness.

Authors:  Nicholas Young; James R Van Brocklyn
Journal:  Exp Cell Res       Date:  2007-02-22       Impact factor: 3.905

6.  Interleukin-1 regulates the expression of sphingosine kinase 1 in glioblastoma cells.

Authors:  Barbara S Paugh; Lauren Bryan; Steven W Paugh; Katarzyna M Wilczynska; Silvina M Alvarez; Sandeep K Singh; Dmitri Kapitonov; Hanna Rokita; Sarah Wright; Irene Griswold-Prenner; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

7.  Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61.

Authors:  Nicholas Young; Dennis K Pearl; James R Van Brocklyn
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

8.  Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.

Authors:  Lauren Bryan; Barbara S Paugh; Dmitri Kapitonov; Katarzyna M Wilczynska; Silvina M Alvarez; Sandeep K Singh; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  Mol Cancer Res       Date:  2008-09       Impact factor: 5.852

Review 9.  Targeting sphingosine-1-phosphate signaling in lung diseases.

Authors:  David L Ebenezer; Panfeng Fu; Viswanathan Natarajan
Journal:  Pharmacol Ther       Date:  2016-09-13       Impact factor: 12.310

10.  Role of Rap1B and tumor suppressor PTEN in the negative regulation of lysophosphatidic acid--induced migration by isoproterenol in glioma cells.

Authors:  Enkhzol Malchinkhuu; Koichi Sato; Tomohiko Maehama; Shogo Ishiuchi; Yuhei Yoshimoto; Chihiro Mogi; Takao Kimura; Hitoshi Kurose; Hideaki Tomura; Fumikazu Okajima
Journal:  Mol Biol Cell       Date:  2009-12       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.